Commercial insight into the pharma and biotech sector.
Global Market Analytics
EvaluatePharma focuses on those companies impacting the commercial market with comprehensive market coverage of listed companies above $50m Market Cap, including full product information and consensus forecasts (where available); our coverage of private companies is continuously updated with new companies added with every update. Most importantly EvaluatePharma eliminates all double accounting to present the most accurate view of the global market.
- Standardized worldwide financial and forecast models for easy benchmarking
- Sales Analysis by Region, Company Rankings & Market Share, Product Sales Rankings & Market Share
- Unique search categories include Therapy Area, Pharma Class, EphMRA ATC code, Technology, Product & Generic Sales
- The most comprehensive historic sales data available from 1986 onwards viewable in over 20 currencies
- Largest catalogue of company disclosed product sales commentary and R&D project commentary
- Charts & MAT analysis provide insightful graphical representation of the latest sales data
- Full history of company M&A deals including deal value,dates and accounting treatment
Register for access to a selection of free analysis and insights